Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_00234
Species: Homo sapiens
Position : chr11:5301549-5302549
Year: 2020
Title: Interrogation of enhancer function by enhancer-targeting CRISPR epigenetic editing
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: hepatocellular carcinoma
PMID:  31980609
MONDO: MONDO:0007256
Tissue: Liver
Tissue Ontology ID: UBERON:0002107
Cell Source: HepG2
CVCL ID: CVCL_0027
Cell Type: hepatocellular carcinoma cell
Cell Ontology ID: CL:0000182
Experiment Type: Enhancer activity assay, Functional perturbation assay
High Throughput Method: ChIP-seq, RNA-seq
Low Throughput Method: CRISPRi, CRISPRa, Luciferase Reporter Assay
About Target Gene
Target gene : HBB
About TF
TF name : FOG1; GATA1; TAL1
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg19) 4 found
Enhancer ID Position Tissue Cell Disease
E_00321 chr11:5301549-5302549 Blood chronic myeloid leukemia cell chronic myeloid leukemia
E_00323 chr11:5301549-5302549 Peripheral Blood T cell adult T-cell leukemia/lymphoma
E_00332 chr11:5301549-5302549 Blood chronic myeloid leukemia cell chronic myeloid leukemia
E_00340 chr11:5301862-5302715 Hematopoietic system chronic myeloid leukemia cell chronic myeloid leukemia
Expression of Target Genes for the Enhancer